Created at 5:36 p.m. Apr, 28, 2026
Author: mohannadkh10
Related Note: 1488855097679 2
Rationale for change

It's contraindicated in the first trimester as it increases the risk of abortion. PDA issues are seen in the second and third trimesters.

https://next.amboss.com/us/article/BN0zWg?q=nsaid%20in%20pregnancy#Z25935fa84695889c0617090889f79360

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
One by one
Empty field
#PANCE::EOR::PEDS #AK_Step1_v12::#Bootcamp::Reproduction::01_Fetal_Development::03_Teratogenic_Medications #AK_Other::^EXPN #AK_Step1_v12::#OME::PreClinical::Musculoskeletal #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::01_NSAIDs #AK_Step2_v12::#SketchyOBGYN::03_Labor_&_Delivery::02_Preterm_Labor_&_Delivery::02_Preterm_Labor #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::11_Headaches::Extra #AK_Step2_v12::#SketchyOBGYN::02_Pregnancy_Complications::02_Fetal_Complications_of_Pregnancy::05_Amniotic_Fluid_Disorders #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::16_Preterm_Labor::Extra #AK_Step1_v12::^Systems::Musculoskeletal::Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::04_NSAIDs #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::01_Obstetrics::01_Normal_Pregnancy::Extra #PANCE::CARDIO::congenital_heart_disease #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::05_Nonsteroidal_anti-inflammatory_drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::05_NSAIDs #AK_Step2_v12::#SketchyOBGYN::01_Prenatal_Care_&_Early_Pregnancy::01_Intro_to_OB::03_Fetal_Physiology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::03_NSAIDs